YR-004

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameYR-004
Drug Alias NameYR-004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtease inhibitors
TargetsProtease
Therapy Area/IndicationsDiabetes Complications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Yirui Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Yirui Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Complications
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A